Surgery – Body protecting or restraining devices for patients or infants – Chafing shields
Reexamination Certificate
2011-04-12
2011-04-12
Brown, Michael A. (Department: 3772)
Surgery
Body protecting or restraining devices for patients or infants
Chafing shields
C128S890000
Reexamination Certificate
active
07921851
ABSTRACT:
One aspect of the present invention relates to a covering member for a protruding portion of a patient's body. This cover is flexible and collapsible so that it conforms to the shape of the encased portion of the body. This prevents the cover from being noticed while it is worn under clothing. The cover can contain a medicament or agent for pretreating a portion of the body before an examination or procedure. When the cover is used to apply a topical anesthetic to a portion of the body for a recommended period of time prior to the procedure or examination commencing, the amount of discomfort experienced by the patient can be significantly reduced compared to the amount experienced by the patient who has the anesthetic applied for just a few moments before the procedure begins. Alternatively, the cover can be used to hold a medicament or agent on the intended portion of the body in order to heal a wound or cure a condition such as a skin rash or the like.
REFERENCES:
patent: 65978 (1867-06-01), Wilder et al.
patent: 3229691 (1966-01-01), Crowe, Jr.
patent: 3782377 (1974-01-01), Rychlik
patent: 3786801 (1974-01-01), Sartorius
patent: 3840012 (1974-10-01), Rushton, Jr.
patent: 3867517 (1975-02-01), Ling
patent: 4036945 (1977-07-01), Haber
patent: 4195639 (1980-04-01), Lee
patent: 4302438 (1981-11-01), Zech
patent: 4311688 (1982-01-01), Burchiel et al.
patent: 4333471 (1982-06-01), Nakai
patent: 4376110 (1983-03-01), David et al.
patent: 4640288 (1987-02-01), Hattori
patent: 4667666 (1987-05-01), Fryslie
patent: 4732864 (1988-03-01), Tolman
patent: 4754750 (1988-07-01), Imonti
patent: 4870977 (1989-10-01), Imonti
patent: 4917112 (1990-04-01), Kalt
patent: 5032103 (1991-07-01), Larsson
patent: 5230350 (1993-07-01), Fentress
patent: 5348860 (1994-09-01), Shamsuddin
patent: 5416025 (1995-05-01), Krepinsky et al.
patent: 5627034 (1997-05-01), Gould et al.
patent: 5740550 (1998-04-01), Yavitz
patent: 5743272 (1998-04-01), Kocher, Jr.
patent: 5798266 (1998-08-01), Quay et al.
patent: 5910125 (1999-06-01), Cummings et al.
patent: 6005159 (1999-12-01), Spier
patent: 6036029 (2000-03-01), Gommel et al.
patent: 6063029 (2000-05-01), Saita et al.
patent: 6093160 (2000-07-01), Augustine et al.
patent: 6096943 (2000-08-01), Maiwald
patent: 6168779 (2001-01-01), Barsky et al.
patent: 6187591 (2001-02-01), Krepinsky et al.
patent: 6221622 (2001-04-01), Love et al.
patent: 6287521 (2001-09-01), Quay et al.
patent: 6570050 (2003-05-01), Augustine et al.
patent: 7487779 (2009-02-01), Kurz et al.
patent: 2001/0034038 (2001-10-01), Huang
patent: 2001/0039015 (2001-11-01), Sauter
patent: 2002/0117169 (2002-08-01), Kurz et al.
patent: 2006/0030787 (2006-02-01), Quay
patent: 2006/0246415 (2006-11-01), Krepinsky et al.
patent: 2008/0096283 (2008-04-01), Krepinsky et al.
patent: 2009/0250074 (2009-10-01), Kurz et al.
patent: 39 07 007 (1990-09-01), None
patent: 1 377 337 (2007-04-01), None
patent: 1 554 584 (2008-05-01), None
patent: 792 353 (1935-12-01), None
patent: 2 150 028 (1985-06-01), None
patent: WO 95/14927 (1995-06-01), None
patent: WO 02/068038 (2002-09-01), None
patent: WO 2004/034059 (2004-04-01), None
patent: WO 2008/141318 (2008-11-01), None
Bobo et al., “Findings from 752081 Clinical Breast Examinations Reported to a National Screening Program From 1995 Through 1998”, Journal of the National Cancer Institute (2000); 92(12): 971-976.
Borg et al., “BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Caner and Are Associated with Later Disease Onset for Less Frequent Mutations”, Disease Marketrs (199); 15: 79-84.
Bradwell et al., “Developments in Antibody Imaging”, in Monoclonal antibodies for cancer detection and therapy (Baldwin RW, Ed.). Academic Press, New York 1985, pp. 65-85.
Breen et al., “Changes in the Use of Screening Mammography: Evidence from the 1987 and 1990 National Health Interview Surveys”, American Journal of Public Health (1994); 84(1): 62-67.
Buckley et al., “Ann efficient method for labeling antibodies with in”, FEBS Lett. (1984); 166(1): 202-204.
David et al., “Protein Iodination with Solid State Lactoperoxidase”, Biochemistry (1974); 13(5): 1014-1021.
Ernster et al., “Incidence of and Treatment for Ductal Carcinoma in Situ of the Breast”, J. Am. Med. Assoc. (1996); 275: 913-918.
Feuer et al., “How Much of the Recent Rise in Breast Cancer Incidence Can be Explained by Increases n Mammography Utilization?”, American Journal of Epidemiology (1992); 136 (12): 1423-1436.
Gotzche et al., “Is screening for breast cancer with mammography justifiable?”, The Lancet (2000); 355: 129-134.
International Search Report dated Aug. 6, 2008 for PCT Application No. PCT/US08/63545 filed May 13, 2008. (001VPC).
International Search Report dated Jul. 16, 2002 for PCT Application No. PCT/US0205202 filed Feb. 22, 2002. (002VPC).
International Search Report dated Apr. 1, 2004 for PCT/CA03/001553 filed Oct. 9, 2003 (003VPC).
Greenlee et al., “Cancer Statistics, 2001”, CA: A Cancer Journal for Clinicians (2001); 51: 15-36.
Greenwood et al., “The Preparation of 131I-Labeled Human Growth Hormone of High Specific Radioactivity”, Biochem. 1963, 89:114-123.
Hayes, D.F., “Tumor markers for breast cancer”, Anals of Oncology (1993); 4: 807-819.
Hnatowich et al., “The Preparation of DTPA-Coupled Antibodies Radiolabled with Metallic Radionuclides: an Improved Method”, Journal of Immunological Methods (1983); 65: 147-157.
Holmberg et al., “Breast cancer mortality in relation to self-reported use of breast self-examination. A cohort study of 450,000 women”, Breast Cancer Research and Treatment (1997); 43: 137-140.
Hunter et al., “Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity”, Nature (1962); 194:495-496.
Katagiri et al., “High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families”, J. Hum. Genet. (1998); 43: 42-48.
Kelsey et al., “Epidemiology and Prevention of Breast Cancer”, Annu. Rev. Public Health (1996); 17: 47-67.
Krepinsky et al., “From T -antigen to plasmalogen-derived aldehydes: The identification of a marker of colorectal cancer in human rectal mucous”, Can. J. Chem. (2003); 81: 109-117.
Kuhl et al., “Healthy Premenopausal Breast Parenchyma in Dynamic Contrast-enhanced MR Imaging of the Breast: Normal Contrast Medium Enhancement and Cyclical-Phase Dependency”, Radiology (1997); 203: 137-144.
Lee et al., “Association of Abnormal Nipple Aspirate Cytology and Mammographic Pattern and Density”, Cancer Epidemiology, Biomarkers & Prevention (1994); 3: 33-36.
Lee et al., “The Association of Dietary Fat with Ability to Obtain Breast Fluid by Nipple Aspiration”, Cancer Epidemiology, Biomarkers & Prevention (1992); 1: 277-280.
Love et al., “Breast-duct endoscopy to study stages of cancerous breast disease”, The Lancet (1996); 348: 997-999.
Mandel et al., “Reducing Mortality From Colorectal Cancer by Screening for Fecal Occult Blood”, New England Journal of Medicine (1993); 328(19): 1365-1371.
Marchalonis, J.J., “An Enzymic Method for the Trace Iodination of Immunoglobulins and other Proteins”, Biochem. J. (1969); 113: 299-305.
Mausner et al., “Epidemiology: An Introductory Text”, pp. 242-243, W.B. Saunders, St. Louis, MO. 1974.
Merchant et al., “P Magnetic resonance phospholipid profiles of neoplastic human breast tissues”, Brit. J. Cancers (1991);63: 693-698.
Morrison et al., “Use of Lactoperoxide Catalyzed Iodination in Immunochemical Studies”, Immunochemistry (1971); 8: 289-297.
Najafi et al., “Coupling Antibody with DTP A-An Alternative to the Cyclic Anhydride”, Int. J. Appl. Radiat. Isot. (1984); 35(6): 554-557.
Olsen et al., “Cochrane review on screening for breast cancer with mammography
Kurz Daniel R.
Seely Lynn
Brown Michael A.
Dr. Susan Love Research Foundation
Knobbe Martens Olson & Bear LLP
LandOfFree
Nipple covering system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nipple covering system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nipple covering system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2628282